{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T12:07:30Z","timestamp":1779365250858,"version":"3.53.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular (English Edition)"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.remnie.2025.500269","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T16:48:45Z","timestamp":1764348525000},"page":"500269","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["In-depth clinical and dosimetric analysis of 166Ho-radioembolization in patients with liver cancer: An observational study"],"prefix":"10.1016","volume":"45","author":[{"given":"R.","family":"S\u00e1 e Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Andr\u00e9 Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Albergueiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.remnie.2025.500269_bib0005","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3390\/cancers16010235","article-title":"Transarterial radioembolization (TARE) in patients with hepatocellular carcinoma: a comparison of palliative with bridging-to-transplant concepts","volume":"16","author":"Sch\u00f6nherr","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.remnie.2025.500269_bib0010","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.semradonc.2019.08.005","article-title":"Transarterial radioembolization for hepatocellular carcinoma and hepatic metastases: clinical aspects and dosimetry models","volume":"30","author":"Mikell","year":"2020","journal-title":"Semin Radiat Oncol"},{"issue":"7","key":"10.1016\/j.remnie.2025.500269_bib0015","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.jvir.2023.03.020","article-title":"Radioembolization for treatment of hepatocellular carcinoma: current evidence and patterns of utilization","volume":"34","author":"Briody","year":"2023","journal-title":"J Vasc Interv Radiol"},{"issue":"4","key":"10.1016\/j.remnie.2025.500269_bib0020","first-page":"153","article-title":"Current status of yttrium-90 microspheres radioembolization in primary and metastatic liver cancer","volume":"6","author":"Anbari","year":"2023","journal-title":"J Interv Med"},{"issue":"1","key":"10.1016\/j.remnie.2025.500269_bib0025","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.annonc.2022.10.003","article-title":"Metastatic colorectal cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up","volume":"34","author":"Cervantes","year":"2023","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.remnie.2025.500269_bib0030","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1102\/1470-7330.2004.0021","article-title":"Embolisation of cancer: what is the evidence?","volume":"4","author":"Goode","year":"2004","journal-title":"Cancer Imaging"},{"key":"10.1016\/j.remnie.2025.500269_bib0035","doi-asserted-by":"crossref","DOI":"10.1002\/anbr.202200166","article-title":"Radioactive microspheres for selective internal radiation therapy of hepatocellular carcinoma","volume":"3","author":"Zhou","year":"2023","journal-title":"Adv NanoBiomed Res"},{"issue":"13","key":"10.1016\/j.remnie.2025.500269_bib0040","doi-asserted-by":"crossref","first-page":"3966","DOI":"10.3390\/molecules26133966","article-title":"Microspheres used in liver radioembolization: from conception to clinical effects","volume":"26","author":"d\u2019Abadie","year":"2021","journal-title":"Molecules"},{"issue":"Suppl 1","key":"10.1016\/j.remnie.2025.500269_bib0045","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1148\/rg.25si055515","article-title":"Yttrium-90 microsphere therapy for hepatic malignancy: devices, indications, technical considerations, and potential complications","volume":"25","author":"Murthy","year":"2005","journal-title":"Radiographics"},{"issue":"23","key":"10.1016\/j.remnie.2025.500269_bib0050","doi-asserted-by":"crossref","first-page":"7245","DOI":"10.3390\/jcm11237245","article-title":"A theranostic approach in SIRT: value of pre-therapy imaging in treatment planning","volume":"11","author":"d\u2019Abadie","year":"2022","journal-title":"J Clin Med"},{"issue":"12","key":"10.1016\/j.remnie.2025.500269_bib0055","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.1007\/s00259-021-05340-0","article-title":"To 1000Gy and back again: a systematic review on dose-response evaluation in selective internal radiation therapy for primary and secondary liver cancer","volume":"48","author":"Roosen","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"10.1016\/j.remnie.2025.500269_bib0060","first-page":"e2895","article-title":"Assessment of treatment response following yttrium-90 transarterial radioembolization of liver malignancies","volume":"10","author":"Adcock","year":"2018","journal-title":"Cureus"},{"issue":"7\u20138","key":"10.1016\/j.remnie.2025.500269_bib0065","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.diii.2014.05.002","article-title":"Imaging criteria for assessing tumour response: RECIST, mRECIST, Cheson","volume":"95","author":"Fournier","year":"2014","journal-title":"Diagn Interv Imaging"},{"issue":"2","key":"10.1016\/j.remnie.2025.500269_bib0070","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jvir.2017.09.024","article-title":"Anatomic versus metabolic tumor response assessment after radioembolization treatment","volume":"29","author":"Jongen","year":"2018","journal-title":"J Vasc Interv Radiol"},{"issue":"1","key":"10.1016\/j.remnie.2025.500269_bib0075","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"EASL clinical practice guidelines: management of hepatocellular carcinoma","volume":"69","year":"2018","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.remnie.2025.500269_bib0080","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1055\/s-2006-939841","article-title":"Epidemiology of primary and secondary liver cancers","volume":"23","author":"Ananthakrishnan","year":"2006","journal-title":"Semin Intervent Radiol"},{"issue":"2","key":"10.1016\/j.remnie.2025.500269_bib0085","first-page":"57","article-title":"Epidemiology of stage IV colorectal cancer: trends in the incidence, prevalence, age distribution, and impact on life span","volume":"37","author":"Ilyas","year":"2023","journal-title":"Clin Colon Rectal Surg"},{"issue":"3","key":"10.1016\/j.remnie.2025.500269_bib0090","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.21037\/jgo-22-882","article-title":"Long-term outcome analysis of Y90 radioembolization in hepatocellular carcinoma","volume":"14","author":"Lee","year":"2023","journal-title":"J Gastrointest Oncol"},{"issue":"4","key":"10.1016\/j.remnie.2025.500269_bib0095","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1007\/s00259-019-04460-y","article-title":"The superior predictive value of 166Ho-scout compared with 99mTc-macroaggregated albumin prior to 166Ho-microspheres radioembolization in patients with liver metastases","volume":"47","author":"Smits","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"10.1016\/j.remnie.2025.500269_bib0100","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1053\/j.semnuclmed.2019.01.006","article-title":"90Y-loaded microsphere SIRT of HCC patients with portal vein thrombosis: high clinical impact of 99mTc-MAA SPECT\/CT-based dosimetry","volume":"49","author":"Garin","year":"2019","journal-title":"Semin Nucl Med"},{"issue":"2","key":"10.1016\/j.remnie.2025.500269_bib0105","first-page":"168","article-title":"Need, feasibility and convenience of dosimetric treatment planning in liver selective internal radiation therapy with (90)Y microspheres: the experience of the National Tumor Institute of Milan","volume":"55","author":"Chiesa","year":"2011","journal-title":"Q J Nucl Med Mol Imaging"},{"issue":"8","key":"10.1016\/j.remnie.2025.500269_bib0110","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.2967\/jnumed.112.117614","article-title":"99mTc-macroaggregated albumin poorly predicts the intrahepatic distribution of 90Y resin microspheres in hepatic radioembolization","volume":"54","author":"Wondergem","year":"2013","journal-title":"J Nucl Med"},{"issue":"10","key":"10.1016\/j.remnie.2025.500269_bib0115","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1007\/s00259-014-2784-9","article-title":"99mTc-MAA overestimates the absorbed dose to the lungs in radioembolization: a quantitative evaluation in patients treated with 166Ho-microspheres","volume":"41","author":"Elschot","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.remnie.2025.500269_bib0120","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1007\/s00259-021-05600-z","article-title":"EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds","volume":"49","author":"Weber","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"10.1016\/j.remnie.2025.500269_bib0125","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1007\/s00259-024-06940-2","article-title":"Holmium-166 radioembolisation dosimetry in HCC","volume":"52","author":"Reinders","year":"2025","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"10.1016\/j.remnie.2025.500269_bib0130","doi-asserted-by":"crossref","first-page":"608","DOI":"10.2967\/jnumed.119.232751","article-title":"First evidence for a dose-response relationship in patients treated with 166Ho radioembolization: a prospective study","volume":"61","author":"Bastiaannet","year":"2020","journal-title":"J Nucl Med"},{"issue":"11","key":"10.1016\/j.remnie.2025.500269_bib0135","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1007\/s00270-022-03215-x","article-title":"Trans-arterial radioembolization dosimetry in 2022","volume":"45","author":"Garin","year":"2022","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"7","key":"10.1016\/j.remnie.2025.500269_bib0140","doi-asserted-by":"crossref","first-page":"747","DOI":"10.3390\/jpm14070747","article-title":"Clinical results of holmium-166 radioembolization with personalized dosimetry for the treatment of hepatocellular carcinoma","volume":"14","author":"K\u00fchnel","year":"2024","journal-title":"J Pers Med"},{"issue":"12","key":"10.1016\/j.remnie.2025.500269_bib0145","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.2967\/jnumed.122.263823","article-title":"Safety and efficacy of 166Ho radioembolization in hepatocellular carcinoma: the HEPAR Primary Study","volume":"63","author":"Reinders","year":"2022","journal-title":"J Nucl Med"},{"issue":"11","key":"10.1016\/j.remnie.2025.500269_bib0150","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/j.hpb.2023.06.011","article-title":"Colorectal liver metastases that survive radioembolization display features of aggressive tumor behavior","volume":"25","author":"Andel","year":"2023","journal-title":"HPB (Oxford)"},{"issue":"4","key":"10.1016\/j.remnie.2025.500269_bib0155","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s12094-023-03299-y","article-title":"Recommendations for the management of yttrium-90 radioembolization in the treatment of patients with colorectal cancer liver metastases: a multidisciplinary review","volume":"26","author":"Gonz\u00e1lez-Flores","year":"2024","journal-title":"Clin Transl Oncol"},{"issue":"4","key":"10.1016\/j.remnie.2025.500269_bib0160","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1055\/s-0041-1735572","article-title":"Radioembolization in the setting of systemic therapies","volume":"38","author":"Mabud","year":"2021","journal-title":"Semin Intervent Radiol"},{"key":"10.1016\/j.remnie.2025.500269_bib0165","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1007\/s00270-022-03270-4","article-title":"Overview of ongoing clinical trials on radioembolization","volume":"45","author":"Fabritius","year":"2022","journal-title":"Cardiovasc Intervent Radiol"}],"container-title":["Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2253808925001752?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2253808925001752?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T11:28:57Z","timestamp":1779362937000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2253808925001752"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S2253808925001752"],"URL":"https:\/\/doi.org\/10.1016\/j.remnie.2025.500269","relation":{},"ISSN":["2253-8089"],"issn-type":[{"value":"2253-8089","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In-depth clinical and dosimetric analysis of 166Ho-radioembolization in patients with liver cancer: An observational study","name":"articletitle","label":"Article Title"},{"value":"Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.remnie.2025.500269","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.remn.2025.500269","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Espa\u00f1a, S.L.U. on behalf of Sociedad Espa\u00f1ola de Medicina Nuclear e Imagen Molecular.","name":"copyright","label":"Copyright"}],"article-number":"500269"}}